Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin J Scanlon

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Biotechnology|November 17, 2004
Anti-genes: siRNA, ribozymes and antisenseKevin J Scanlon
Anticancer Research|May 22, 2004
Cancer gene therapy: challenges and opportunitiesKevin J Scanlon
Cytotechnology|November 13, 2008
Commercializing medical technologyKevin J Scanlon, Mark A Lieberman
Anticancer Research|May 22, 2004
Construction and transfection of a ribozyme targeting human caspase-3Deirdre Cronin, Carmel Daly, Toni O'Doherty, et al.
International Journal of Oncology|February 10, 2004
Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancerHiroshi Kijima, Hitoshi Yamazaki, Masato Nakamura, et al.
International Journal of Oncology|October 9, 2002
Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 geneJunko Nagata, Hiroshi Kijima, Hiroyuki Hatanaka, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Biotechnology|November 17, 2004
Anti-genes: siRNA, ribozymes and antisenseKevin J Scanlon
Anticancer Research|May 22, 2004
Cancer gene therapy: challenges and opportunitiesKevin J Scanlon
Cytotechnology|November 13, 2008
Commercializing medical technologyKevin J Scanlon, Mark A Lieberman
Anticancer Research|May 22, 2004
Construction and transfection of a ribozyme targeting human caspase-3Deirdre Cronin, Carmel Daly, Toni O'Doherty, et al.
International Journal of Oncology|February 10, 2004
Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancerHiroshi Kijima, Hitoshi Yamazaki, Masato Nakamura, et al.
International Journal of Oncology|October 9, 2002
Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 geneJunko Nagata, Hiroshi Kijima, Hiroyuki Hatanaka, et al.
Pageof 1